GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 78 filers reported holding GENERATION BIO CO in Q3 2023. The put-call ratio across all filers is 2.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,463,113 | -30.7% | 913,750 | +0.6% | 0.00% | – |
| Q2 2023 | $4,997,922 | +29.6% | 908,713 | +1.3% | 0.00% | – |
| Q1 2023 | $3,856,008 | -47.0% | 896,746 | -51.5% | 0.00% | – |
| Q4 2022 | $7,268,928 | +49.0% | 1,849,600 | +101.4% | 0.00% | – |
| Q3 2022 | $4,877,000 | -18.7% | 918,491 | +0.4% | 0.00% | – |
| Q2 2022 | $6,002,000 | -4.8% | 914,928 | +6.5% | 0.00% | – |
| Q1 2022 | $6,305,000 | -54.3% | 858,936 | -55.9% | 0.00% | -100.0% |
| Q4 2021 | $13,791,000 | -69.7% | 1,947,909 | +7.5% | 0.00% | -50.0% |
| Q3 2021 | $45,441,000 | -24.7% | 1,812,552 | -19.2% | 0.00% | -33.3% |
| Q2 2021 | $60,369,000 | +0.4% | 2,244,201 | +6.2% | 0.00% | 0.0% |
| Q1 2021 | $60,125,000 | +297.1% | 2,112,627 | +295.6% | 0.00% | +200.0% |
| Q4 2020 | $15,140,000 | +239.8% | 534,056 | +270.5% | 0.00% | – |
| Q3 2020 | $4,456,000 | – | 144,162 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8,278,876 | $58,614,000 | 5.38% |
| Yiheng Capital Management, L.P. | 1,975,146 | $13,984,000 | 0.71% |
| Artal Group S.A. | 2,814,191 | $19,924,000 | 0.54% |
| HARVARD MANAGEMENT CO INC | 510,354 | $3,613,000 | 0.34% |
| Bellevue Group AG | 3,872,180 | $27,416,000 | 0.28% |
| Casdin Capital, LLC | 1,324,275 | $9,376,000 | 0.26% |
| FARALLON CAPITAL MANAGEMENT LLC | 3,500,000 | $24,780,000 | 0.12% |
| BVF INC/IL | 189,050 | $1,338,000 | 0.05% |
| PDT Partners, LLC | 36,843 | $261,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 17,739 | $126,000 | 0.02% |